EE389 Social and Economic Impact of Adverse Events in Switching from Pentavalent Whole Cell Pertussis to Hexavalent Acellular Vaccine for All Infants in Brazil

Abstract

This study aims to demonstrate the costs related to Adverse Events Post Vaccination (AEPV) of diphtheria, tetanus, whole-cell pertussis [DTwP] / hepatitis B [HB]/ Haemophilus influenzae type b [Hib] plus inactivated polio vaccine [IPV], and oral polio vaccine [OPV] (current scenario) versus the introduction of a fully liquid, hexavalent, acellular diphtheria, tetanus, and acellular pertussis [DTaP]-IPV/HB/Hib vaccine (alternative scenario) in the Brazilian public, private and social perspectives.